A4SG27 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihb43a2mg2h2suvxfv7to3we7qkbncopkfsvhndjklpxk5takegum/metadata.json
IPFS of structure file: 
bafybeidni6ptoxkst6qolq4yar5lmjplqayca33dzzlu3czh3asserzela/AF-A4SG27-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x66026B7eDA2C7707c7042FCF1BE7d1A483c4dD3c
First NFT owner address (bech32): 
genesis1vcpxklk693ms03cy9l83he735jpufhfuey76wf
Current NFT ID #449953 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
449953
Accession (UniProt):
A4SG27
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Chlorobium phaeovibrioides (strain DSM 265 / 1930)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A4SG27 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A4SG27|SYL_CHLPM Leucine--tRNA ligase OS=Chlorobium phaeovibrioides (strain DSM 265 / 1930) OX=290318 GN=leuS PE=3 SV=1 MRYDFSKTEKKWQARWKQQETFKTGEAPEKPKYYVLDMFPYPSGSGLHVGHLEGYTASDISARYRRSRGYNVLHPMGWDAFGLPAEQFAIKTGTHPSDTTQKNIANFKETLQAMGFSYDWSREINTTDPGYFQWTQWIFLKLHEMGLAYMSEVDVNWCVELRAVLANEEVEEKLADGLTVVRRPLRQWVLKITAYADRLLEDLDGLDWPENVKQMQRNWIGRSEGVEVDFELRCHRTMLRVYTTRPDTLFGATYLVISPEHAMAEKLATAQQLVAVKEYIAKAKLKTELERTGLQKDKTGVFTGSYAINPATGEPLPVWISDFVLTSYGTGAIMSVPAHDSRDWEFAKQYGLPIIEVVKSPHDVQQEVFEGKDSTVVNSSNNDISLNGLAFPEAFELMASWLEKKKAGKRKVNYRLRDWIFSRQRYWGEPIPIKHYPDGTLKPETSLPLMLPEVEAYQPTETGESPLANIPEWLNGTDENGPFRRETNTMPQWAGSCWYYLRFIDPHNSKLPVDPAKEAYWMNVDLYIGGAEHAVLHLLYARFWHKVLFDLKVVSTKEPFQRLFNQGMILGEDNEKMSKSRGNVIPADHVLQTYGADAVRLYEMFLGPLEQVKPWNTNGIEGISRFLSRVWRLVWPEPEGTRADLSTLAPSPDLLRRMHKTIKKVAADTENLKFNTAIAEMMVFTNELHRTGEGSRIAVETLLLLLAPYAPHLSEELWEALGHQESISLAPFPEFDPELAQDKEVTIAVQVNGKLRGSFTAAPGSPKEQLLNEAKALEGVKKFLEGVTIMKEIVVPDKLINFAVK